Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Toni K. Choueiri; Thomas Powles; Mauricio Burotto; Bernard Escudier; Maria T. Bourlon; Bogdan Zurawski; Victor M. Oyervides Juárez; James J. Hsieh; Umberto Basso; Amishi Y. Shah

doi:10.1056/nejmoa2026982

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Identifier:nobleid.org/w1/20260526/8EC5DDB0

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/8EC5DDB0.svg?ark=w1%2F20260526%2F8EC5DDB0)](https://nobleid.org/work/w1/20260526/8EC5DDB0)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Victor M. Oyervides Juárez

James J. Hsieh

Umberto Basso

Amishi Y. Shah

Claim authorship of this work

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Identifier:nobleid.org/w1/20260526/8EC5DDB0

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/8EC5DDB0.svg?ark=w1%2F20260526%2F8EC5DDB0)](https://nobleid.org/work/w1/20260526/8EC5DDB0)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Victor M. Oyervides Juárez

James J. Hsieh

Umberto Basso

Amishi Y. Shah

Claim authorship of this work